These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29557932)

  • 1. Trends and Determinants of Polypharmacy and Potential Drug-Drug Interactions at Discharge From Hospital Between 2009-2015.
    Abolhassani N; Castioni J; Santschi V; Waeber G; Marques-Vidal P
    J Patient Saf; 2021 Dec; 17(8):e1171-e1178. PubMed ID: 29557932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.
    Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
    Drugs Aging; 2009; 26(6):493-503. PubMed ID: 19591524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-drug interactions associated with length of stay and cost of hospitalization.
    Moura CS; Acurcio FA; Belo NO
    J Pharm Pharm Sci; 2009; 12(3):266-72. PubMed ID: 20067703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States.
    Sheikh-Taha M; Asmar M
    BMC Geriatr; 2021 Apr; 21(1):233. PubMed ID: 33827442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-Year Trend in Polypharmacy in the Lausanne Population.
    Abolhassani N; Vollenweider P; Waeber G; Marques-Vidal P
    J Patient Saf; 2021 Jun; 17(4):e269-e273. PubMed ID: 32168266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial.
    Zerah L; Henrard S; Wilting I; O'Mahony D; Rodondi N; Dalleur O; Dalton K; Knol W; Haschke M; Spinewine A
    BMC Geriatr; 2021 Oct; 21(1):571. PubMed ID: 34663238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Changes in Medication Prescribing Among the Older People with Cognitive Impairment in the Acute Care Setting.
    Ruangritchankul S; Peel NM; Shafiee Hanjani L; Gray LC
    Clin Interv Aging; 2020; 15():865-876. PubMed ID: 32606626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid prescribing and risk of drug-opioid interactions in older discharged patients with polypharmacy in Australia.
    Al-Qurain AA; Gebremichael LG; Khan MS; Williams DB; Mackenzie L; Phillips C; Russell P; Roberts MS; Wiese MD
    Int J Clin Pharm; 2021 Apr; 43(2):365-374. PubMed ID: 33206289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
    Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy and potential drug-drug interactions in emergency department patients in the Caribbean.
    Dookeeram D; Bidaisee S; Paul JF; Nunes P; Robertson P; Maharaj VR; Sammy I
    Int J Clin Pharm; 2017 Oct; 39(5):1119-1127. PubMed ID: 28795285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification.
    Carmona-Huerta J; Castiello-de Obeso S; Ramírez-Palomino J; Duran-Gutiérrez R; Cardona-Muller D; Grover-Paez F; Fernández-Dorantes P; Medina-Dávalos R
    BMC Psychiatry; 2019 Feb; 19(1):78. PubMed ID: 30791883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
    Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
    J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients.
    Leger DY; Moreau S; Signol N; Fargeas JB; Picat MA; Penot A; Abraham J; Laroche ML; Bordessoule D
    J Geriatr Oncol; 2018 Jan; 9(1):60-67. PubMed ID: 28851511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients.
    Rosas-Carrasco O; García-Peña C; Sánchez-García S; Vargas-Alarcón G; Gutiérrez-Robledo LM; Juárez-Cedillo T
    Rev Invest Clin; 2011; 63(6):564-73. PubMed ID: 23650669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study.
    Hughes JE; Russo V; Walsh C; Menditto E; Bennett K; Cahir C
    Drugs Aging; 2021 Nov; 38(11):1025-1037. PubMed ID: 34632551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.
    López-Centeno B; Badenes-Olmedo C; Mataix-Sanjuan Á; McAllister K; Bellón JM; Gibbons S; Balsalobre P; Pérez-Latorre L; Benedí J; Marzolini C; Aranguren-Oyarzábal A; Khoo S; Calvo-Alcántara MJ; Berenguer J
    Clin Infect Dis; 2020 Jul; 71(2):353-362. PubMed ID: 31428770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interactions in a cohort of hospitalized elderly patients.
    Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.